Aliso Viejo, CA, Jan. 10, 2018 (GLOBE NEWSWIRE) — OrthAlign, Inc., a leading provider of orthopedic surgical navigation solutions, announced today that Dr. Steven Haas, Chief of the Knee Service at Hospital for Special Surgery in New York, NY, has joined the company’s Executive Surgeon Council (“ESC”) advisory board.
The ESC works closely with OrthAlign’s management team and product development group, bringing innovative products to market built upon proprietary, sensor-based surgical navigation technologies. The company’s flagship product, KneeAlign®, uses instrument-mounted sensor navigation to provide real-time guidance during primary total knee replacement procedures. OrthAlign launched UniAlign™ in early 2017, bringing the accuracy and consistency of KneeAlign to partial knee replacement surgery, opening opportunities for customers to bring impactful computer navigation into surgery centers.
“We are so pleased to have Dr. Haas join our very talented and engaged board of surgeon advisors, and to bring with him his wealth of experience and history of innovation in this space,” commented Eric B. Timko, Chairman and CEO of OrthAlign. “As we continue to expand our platform of indications, we look forward to evolving KneeAlign and building a suite of applications that make OrthAlign’s technologies the go-to solution for their ease of use, economics, and clinical results.”
“I am excited to join OrthAlign’s outstanding clinical and management teams as they continue to expand and more broadly apply their proven sensor technology,” said Dr. Steven Haas. “OrthAlign has innovative products, and I look forward to working with them as they expand their platform.”
Dr. Haas speaks nationally and internationally on hip and knee topics, and has contributed more than 90 publications into orthopedic literature. He is well known for development of ground-breaking surgical technique and instrumentation for performing minimally invasive knee replacement; along with development of high performance knee replacement systems. Dr. Haas received his education and training at Harvard, Cornell and the University of Rochester.
ORTHALIGN, INC.
OrthAlign is a privately held medical device and technology company, developing advanced technologies that deliver healthier and more pain-free lifestyles to joint replacement patients, globally. We provide healthcare professionals with cutting edge, computer-assisted surgical tools that seamlessly and cost-effectively deliver vital data and clinical results to optimize outcomes for our patients. For more information regarding OrthAlign, please visit www.orthalign.com or contact Adam Simone (asimone@orthalign.com).
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/070ff4f7-3771-4d0f-a87d-d457737c24c1
Adam Simone OrthAlign asimone@orthalign.com
